Indicated in combination with metronidazole in patients 18 years or older for the treatment of complicated intra-abdominal infections (cIAI) caused by designated susceptible microorganisms.
Indicated in patients 18 years or older for the treatment of complicated urinary tract infections (cUTI) (including pyelonephritis) caused by designated susceptible microorganisms.
Indicated in patients 18 years or older for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by designated susceptible microorganisms.